Pradaxa (dabigatran etexilate)

pCPA File Number: 20784

Negotiation Status:

Concluded with an LOI

Indication(s):

Atrial fibrillation prevention of stroke and systemic embolism

Sponsor/Manufacturer:

Boehringer Ingelheim (Canada) Ltd.

CDA-AMC Project Number:

SR0214-000

pCPA Engagement Letter Issued:

2013-08-21

Negotiation Process Concluded:

2012-03-22